Eli Lilly investors and analysts said they want to hear details from the company on how exactly it plans to grow U.S. sales ...

In fact, Novo Nordisk recently reported positive results for one of its anti-obesity candidates that puts its current ...

Drugmakers have poured small fortunes into the development of weight loss medicines in the past ... that puts its current best-selling drug in this area, Wegovy, to shame. Let's look deeper ...

Novo Nordisk reported Q4 sales of $11.96 billion, beating estimates. The company plans a new phase 3 trial for CagriSema in ...

Ozempic and Wegovy maker Novo Nordisk quieted Wall Street’s concerns with its fourth-quarter results and 2025 outlook.

Wegovy: sales of weight loss injection more than double - The company said more than 45 million people were now ‘benefitting ...

Lange explained on a conference call that one reason for the miss was a flexible treatment protocol that allowed patients to ...